Move to topTop

NEW DELHI, July 11, 2023, Terumo India, the Indian arm of Terumo Corporation (TSE: 4543), a global leader in medical technology, today announced that it has been recognized amongst India's Great Mid-Size Workplaces™ conferred by the Great Place to Work® Institute, India. The assessment aims at studying the ways in which organizations fully channelise the people power and create inclusive workplaces through effective leadership, meaningful values and a culture where all employees experience high levels of trust, such that each employee is able to bring their best self to work. 

Expressing his delight over achieving the honour Mr. Shishir Agarwal, President and Managing Director of Terumo India said, “2022 was a momentous year for Terumo India as we surpassed new growth milestones, established new partnerships and introduced innovative new products for patients in India. As we soar to newer heights, the driving force of our success has truly been the passion and commitment of our dedicated associates. It is their trust and belief in our vision and values that nurtures the people-centric culture of the organization and drives our collective progress.”

Ranked 77 in the listing of the Top 100 Companies, Terumo India’s latest success at the India's Great Mid-Size Workplaces™ builds on the consistent recognition it has received in previous years for its progressive and enabling work practices including as a Great Place to Work® in 2021 and 2022, and as one of the Top 15 Companies in India's Best Workplaces™ in Pharmaceuticals, Healthcare and Biotech 2022. 

As part of the assessment for India's Great Mid-Size Workplaces™, all organizations are studied through two lenses: a Trust Index© that measures the quality of employee experience and a Culture Audit© that evaluates the strength of the leadership as supported by meaningful values & philosophy and quality of the practices & programs. 

Speaking on the occasion, Ritu Anand, Senior Director - Human Resources, Administration and Corporate Communications, Terumo India, said, "Living by a philosophy of being powered by people, we have firmly established our talent ecosystem on the three fundamental pillars of ensuring associate well-being, enhancing competence of our talent, and nurturing our culture. Some of our recent initiatives, such as increased maternity leave, phased reintegration of returning mothers, introduction of pet care leave, and menstrual leave, have been highly appreciated by our associates and have set new benchmarks in the industry. By placing our associates at the centre of our efforts, we empower them to thrive both personally and professionally."

About Terumo India

Terumo India is a fast-growing medical devices company that serves to advance access of high-quality Cardiac & Vascular and other medical devices to patients and medical practitioners in India. Terumo India is part of Terumo Corporation, a global leader in medical technology with headquarters in Tokyo, Japan and over 30,000 associates worldwide. Established in 1921 and with its more than 100 years of history, Terumo’s starting point and unchanging corporate mission has been ‘Contributing to Society through Healthcare.’

Terumo India was established in 2013 with headquarters in Gurgaon, NCR Delhi and has since grown to touch over 100,000 lives, with an expanding field force & distribution network. Terumo India is Great Place to Work® certified and has also been recognized as one of India’s Top 15 Workplaces ™ in Pharmaceuticals, Healthcare and Biotech 2022. The company runs several acclaimed training & development programs, working closely with its customers and academic partners, to contribute to the skilling requirements of India’s healthcare system. 

For more information, visit

About Terumo

Terumo (TSE: 4543) is a global leader in medical technology and has been committed to “Contributing to Society through Healthcare” for 100 years. Based in Tokyo and operating globally, Terumo employs more than 30,000 associates worldwide to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been supporting healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice such as transfusion systems, diabetes care, and peritoneal dialysis treatments. Terumo will further strive to be of value to patients, medical professionals, and society at large.

Among the information that Terumo discloses, the forward-looking statements including financial projections are based upon our assumptions using information available to us at the time and are not intended to be guarantees of future events or performance. Accordingly, it should be noted that actual results may differ from those forecasts or projections due to various factors. Factors affecting to actual results include, but are not limited to, changes in economic conditions surrounding Terumo, fluctuations of foreign exchange rates, and state of competition.


Information about products (including products currently in development) included in this material is not intended to constitute an advertisement or medical advice.